Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

1.

Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.

Boyanov MA, Boneva Z, Christov VG.

Aging Male. 2003 Mar;6(1):1-7.

PMID:
12809074
[PubMed - indexed for MEDLINE]
2.

Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.

Yassin DJ, Doros G, Hammerer PG, Yassin AA.

J Sex Med. 2014 Jun;11(6):1567-76. doi: 10.1111/jsm.12523. Epub 2014 Apr 8.

PMID:
24712761
[PubMed - indexed for MEDLINE]
3.

Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control.

Corrales JJ, Burgo RM, Garca-Berrocal B, Almeida M, Alberca I, González-Buitrago JM, Orfao A, Miralles JM.

Metabolism. 2004 May;53(5):666-72.

PMID:
15131775
[PubMed - indexed for MEDLINE]
4.

Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.

Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P; BLAST Study Group.

J Sex Med. 2014 Mar;11(3):840-56. doi: 10.1111/jsm.12404. Epub 2013 Dec 6.

PMID:
24308723
[PubMed - indexed for MEDLINE]
5.

[Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].

Kalinchenko SIu, Vorslov LO, Aglamazian NL, Morgunov LIu.

Urologiia. 2007 Jan-Feb;(1):57, 59-61. Russian.

PMID:
17472002
[PubMed - indexed for MEDLINE]
6.

The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.

Traish AM, Guay A, Feeley R, Saad F.

J Androl. 2009 Jan-Feb;30(1):10-22. doi: 10.2164/jandrol.108.005215. Epub 2008 Jul 17. Review.

PMID:
18641413
[PubMed - indexed for MEDLINE]
Free Article
7.

Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study.

Li JY, Zhu JC, Dou JT, Bai WJ, Deng SM, Li M, Huang W, Jin H.

Aging Male. 2002 Mar;5(1):47-51.

PMID:
12040975
[PubMed - indexed for MEDLINE]
8.

Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.

Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B.

Horm Metab Res. 2004 Jan;36(1):54-61.

PMID:
14983408
[PubMed - indexed for MEDLINE]
9.

Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.

Kapoor D, Goodwin E, Channer KS, Jones TH.

Eur J Endocrinol. 2006 Jun;154(6):899-906.

PMID:
16728551
[PubMed - indexed for MEDLINE]
Free Article
10.

[The relationship between testosterone and dehydroepiandrosterone sulfate concentrations, insulin resistance and visceral obesity in elderly men].

Rabijewski M, Kozakowski J, Zgliczyński W.

Endokrynol Pol. 2005 Nov-Dec;56(6):897-903. Polish.

PMID:
16821208
[PubMed - indexed for MEDLINE]
11.

Role of endogenous androgen against insulin resistance and athero- sclerosis in men with type 2 diabetes.

Fukui M, Kitagawa Y, Ose H, Hasegawa G, Yoshikawa T, Nakamura N.

Curr Diabetes Rev. 2007 Feb;3(1):25-31. Review.

PMID:
18220653
[PubMed - indexed for MEDLINE]
12.

The effect of testosterone supplement on insulin sensitivity, glucose effectiveness, and acute insulin response after glucose load in male type 2 diabetics.

Lee CH, Kuo SW, Hung YJ, Hsieh CH, He CT, Yang TC, Lian WC, Chyi-Fan S, Pei D.

Endocr Res. 2005;31(2):139-48.

PMID:
16353672
[PubMed - indexed for MEDLINE]
13.

[Safety of long-term replacement hormonal therapy in patients with erectile dysfunction and androgen deficiency].

Morgunov LIu, Vertkin AL, Pushkar' DIu.

Urologiia. 2007 Sep-Oct;(5):49-51. Russian.

PMID:
18254226
[PubMed - indexed for MEDLINE]
14.

Relative androgen deficiency in relation to obesity and metabolic status in older men.

Chen RY, Wittert GA, Andrews GR.

Diabetes Obes Metab. 2006 Jul;8(4):429-35.

PMID:
16776750
[PubMed - indexed for MEDLINE]
15.

The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.

Traish AM, Saad F, Guay A.

J Androl. 2009 Jan-Feb;30(1):23-32. doi: 10.2164/jandrol.108.005751. Epub 2008 Sep 4. Review.

PMID:
18772488
[PubMed - indexed for MEDLINE]
Free Article
16.

[PADAM from the urologic viewpoint].

Ludwig G.

Urologe A. 2000 Sep;39(5):407-10. Review. German.

PMID:
11045038
[PubMed - indexed for MEDLINE]
17.

Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.

Corrales JJ, Almeida M, Burgo R, Mories MT, Miralles JM, Orfao A.

J Endocrinol. 2006 Jun;189(3):595-604.

PMID:
16731790
[PubMed - indexed for MEDLINE]
Free Article
18.

Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?

Haren MT, Morley JE, Chapman IM, O'Loughlin PD, Wittert GA.

Climacteric. 2002 Mar;5(1):15-25. Review.

PMID:
11974555
[PubMed - indexed for MEDLINE]
19.

Total and free testosterone concentrations are strongly influenced by age and central obesity in men with type 1 and type 2 diabetes but correlate weakly with symptoms of androgen deficiency and diabetes-related quality of life.

Biswas M, Hampton D, Newcombe RG, Rees DA.

Clin Endocrinol (Oxf). 2012 May;76(5):665-73. doi: 10.1111/j.1365-2265.2011.04196.x.

PMID:
21854402
[PubMed - indexed for MEDLINE]
20.

Androgen deficiency in the etiology and treatment of erectile dysfunction.

Gore JL, Swerdloff RS, Rajfer J.

Urol Clin North Am. 2005 Nov;32(4):457-68, vi-vii. Review.

PMID:
16291037
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk